Author: David Fisher

Cellular Biomedicine Group and Novartis Partner to Bring CAR-T Cancer Therapy to China

Cellular Biomedicine Group and Novartis Partner to Bring CAR-T Cancer Therapy to China

Shares of Cellular Biomedicine Group (CBMG) have resumed pre-market activity after a brief halt following the company’s announcement Thursday that it has entered into a strategic licensing and collaboration agreement with Novartis (NVS) to manufacture and supply the CAR-T cell therapy Kymriah in China. Novartis will be the the exclusive holder of the marketing license. Under the terms of the […]

Wall Street Set For Gains After Fed Rate Hike, Q2 GDP Growth Steady at 4.2%

Wall Street Set For Gains After Fed Rate Hike, Q2 GDP Growth Steady at 4.2%

US stocks were set for a positive open on Thursday as traders evaluated the latest monetary-policy decision by the Federal Reserve and a deluge of readings on the US economy. Oil prices nudged higher with global benchmark Brent Crude up 0.71%, and US crude West Texas Intermediate up 1.15% recently as markets prepare for the imposition of fresh US sanctions […]